Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 8/20 | 0.41 |
| ▸ | REN | P00797 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5114651 | 1.00 | ACE (0.41) | ACERENLMNACYP2C19HSD17B10 | |
| SCHEMBL24133161 | 1.00 | ACE (0.41) | ACERENLMNACYP2C19HSD17B10 | |
| SCHEMBL14369222 | 1.00 | ACE (0.41) | ACERENLMNACYP2C19HSD17B10 | |
| SCHEMBL2928936 | 0.94 | ALDH1A1 (0.36) | ACE | |
| SCHEMBL2928932 | 0.94 | ALDH1A1 (0.36) | ACE | |
| SCHEMBL2522460 | 0.92 | L3MBTL1 (0.36) | ACE | |
| SCHEMBL29955898 | 0.86 | — | — | |
| SCHEMBL10552586 | 0.86 | — | — | |
| SCHEMBL2926280 | 0.81 | CA12 (0.38) | — | |
| SCHEMBL3507032 | 0.80 | ACE (0.40) | ACERENLMNACYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122015636-A | Device and method for improving performance of NPRO (non-return-to-zero) self-feedback interferometer through magnetic field frequency stabilization | 中山大学 | 2026-05-12 | — | — | CN | claimed |
| US-12569548-B2 | RNA construct | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2026-03-10 | — | — | US | claimed |
| US-12473562-B2 | Optimized host/vector system for producing protective mono-and multivalent subunit vaccines on the basis of the yeast Kluyveromyces lactis | VEROVACCINES GMBH (DE) | 2025-11-18 | — | — | US | claimed |
| US-20250325645-A1 | BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | UNIV KANSAS STATE (US) | 2025-10-23 | — | — | US | claimed |
| WO-2025202351-A1 | OPTICAL SOURCE | NKT PHOTONICS A/S (DK) | 2025-10-02 | — | — | WO | claimed |
| WO-2025202350-A1 | OPTICAL SOURCE | NKT PHOTONICS A/S (DK) | 2025-10-02 | — | — | WO | claimed |
| EP-4625724-A1 | OPTICAL SOURCE | NKT Photonics A/S (DK) | 2025-10-01 | — | — | EP | claimed |
| EP-4625725-A1 | OPTICAL SOURCE | NKT Photonics A/S (DK) | 2025-10-01 | — | — | EP | claimed |
| US-20250257121-A1 | PREPARATION OF TARGET PEPTIDES AND PROTEINS | PROTEVO BIO UG (LIMITED LIABILITY (DE) | 2025-08-14 | — | — | US | claimed |
| EP-4598946-A1 | NUCLEIC ACID MOLECULES ENCODING TRIF AND ADDITIONALPOLYPEPTIDES AND THEIR USE IN TREATING CANCER | Flagship Pioneering Innovations V, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| US-20170362466-A1 | Chemical Mechanical Polishing (CMP) of Cobalt-Containing substrate | VERSUM MATERIALS US, LLC (US) | 2017-12-21 | — | — | US | claimed |
| EP-3257910-A1 | CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION, METHOD AND SYSTEM FOR COBALT-CONTAINING SUBSTRATE | Versum Materials US, LLC (US) | 2017-12-20 | — | — | EP | claimed |
| CN-105295737-A | Chemical mechanical polishing (CMP) of cobalt-containing substrate | AIR PROD & CHEM | 2016-02-03 | — | — | CN | claimed |
| US-20160027657-A1 | Chemical Mechanical Polishing (CMP) of Colbalt-Containing Substrate | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-01-28 | — | — | US | claimed |
| EP-2977418-A1 | CHEMICAL MECHANICAL POLISHING (CMP) OF COBALT-CONTAINING SUBSTRATE | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-01-27 | — | — | EP | claimed |
| EP-1668008-A4 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2009-02-25 | — | — | EP | claimed |
| EP-1668008-A2 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2005023183-A2 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-17 | — | — | WO | claimed |
| US-20050059655-A1 | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use | NITROMED, INC. (US) | 2005-03-17 | — | — | US | claimed |
| US-3987058-A | PREPARATION AND USES OF STABLE, BOUND STATIONARY PHASES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1976-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059655-A1 | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use | REN, NOS1, NOS3 | ACE 150/4885REN 1/4885LMNA 615/4885 |
| US-12569548-B2 | RNA construct | SARNP, EIF2AK2, MAVS | ACE 508/4885REN 1490/4885LMNA 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.